Switching medications may decrease treatment burden and macular fluid
Greater central subfield thickness and better visual acuity at baseline are associated with longer time to resolution
Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy